STOCK COMMENTS / EPS CHANGESAnn (ANN) estimates, price target were raised at UBS. Shares are now seen reaching $40. Estimates were also increased, as higher sales are driving margin expansion, UBS said. Buy rating. HollyFrontier (HFC) numbers raised at Oppenheimer. Shares are now seen reaching $46. Estimates were also raised on mid-con crude advantage, Oppenheimer said. Outperform rating. Highwoods Properties (HIW) price target was lowered at Jefferies to $36. Trends somewhat mixed, Jefferies said. Hold rating. Innophos (IPHS) estimates, price target reduced at Keybanc. IPHS estimates were cut through 2013. Company has a lower outlook for GTSP, Keybanc said. Buy rating and new $63 price target. Mindray Medical (MR) numbers were raised at Oppenheimer. Shares are now seen reaching $39. Estimates also raised on conservative guidance setting stage for more beats, Oppenheimer said. Outperform rating. Williams Sonoma (WSM - Get Report) numbers were increased at UBS. WSM estimates were raised through 2014. Company should see higher sales growth and better operating leverage, UBS said. Neutral rating and new $39 price target. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.